In addition to the above-reported linc-ROR-induced EMT in breast cancer, Peng et al. found that linc-ROR regulates estrogen-independent growth (EIG) and drug resistance in breast cancer through the MAPK/ERK signaling pathway. Here, LINC-ROR is linked to breast cancer.